Condoms and Vasectomies Aren’t Enough—Is a Male Birth Control Pill Next?

Science Quickly

Scientific American

Science

4.3 • 1.4K Ratings

🗓️ 13 August 2025

⏱️ 10 minutes

🔗️ Recording | iTunes | RSS

🧾️ Download transcript

Summary

In this episode, host Rachel Feltman speaks with freelance science journalist Hannah Seo about a promising new development in male contraception: a hormone-free birth control pill that reversibly stops sperm production has just passed its first human safety trial. Seo explains how the drug works, what makes it different from hormone-based methods and where it stands in clinical development. Recommended reading: First Hormone-Free Male Birth Control Pill Shown Safe in Early Human Trial Male Birth Control Is in Development, but Barriers Still Stand in the Way “Safety and Pharmacokinetics of the Non-Hormonal Male Contraceptive YCT-529,” by Nadja Mannowetz et al., in Communications Medicine, Vol. 5, Article No. 279. Published online July 22, 2025 Email us at [email protected] if you have any questions, comments or ideas for stories we should cover! Discover something new every day: subscribe to Scientific American and sign up for our daily newsletter. Science Quickly is produced by Rachel Feltman, Fonda Mwangi, Kelso Harper and Jeff DelViscio. This episode was edited by Alex Sugiura. Shayna Posses and Aaron Shattuck fact-check the show. The theme music was composed by Dominic Smith. Learn more about your ad choices. Visit megaphone.fm/adchoices

Transcript

Click on a timestamp to play from that location

0:00.0	While you enjoy this podcast, remember to reserve your place at the unmissable Keer Electric Experience.
0:05.6	On show will be our highly anticipated new electric vehicles, the sporty Kier EV4, an athletic hatchback, and an SUV with a perfect blend of versatility and performance, the Kier EV5.
0:17.0	Discover our award-winning electric range, including this year's UK and World Car of the Year, the EV3.
0:22.9	Secure your exclusive place today.
0:25.0	Search the Kia Electric Experience.
0:27.1	Kia, Movement that Inspires.
0:30.1	I'm Steve Strogatz.
0:31.7	And I'm Jan 11.
0:32.9	And this season on The Joy of Why from Quantum Magazine, we're sitting down together.
0:37.4	We have our own research areas, but we don't always get the chance to speak deeply about science. season on The Joy of Why from Quantum Magazine, we're sitting down together.
0:37.5	We have our own research areas, but we don't always get the chance to speak deeply about
0:41.3	science and math beyond our fields.
0:43.3	We'll ask researchers about moments big and small that inspire them and lead to incredible
0:48.1	discoveries.
0:49.3	Lots of science news outlets provide coverage on applied work like health and tech, but we
0:53.6	cover big questions in the
0:55.0	study of life, reality, numbers, and information. We hope these stories spark your curiosity, too.
1:01.0	Join us for the joy of why from Quantum Magazine. For Scientific American Science quickly, I'm Rachel Feldman.
1:22.8	When it comes to birth control, men have exactly two reliable options, condoms or a
1:33.4	vasectomy. That's it. For decades, researchers have been working to expand those choices,
1:39.0	but progress has been slow. Now, a new pill for men has just passed its first safety trial in humans. What's
1:47.0	particularly exciting about this daily pill, which works by blocking a key step in sperm production,
	...

Please login to see the full transcript.

Previous episode | Next episode

Disclaimer: The podcast and artwork embedded on this page are from Scientific American, and are the property of its owner and not affiliated with or endorsed by Tapesearch.

Generated transcripts are the property of Scientific American and are distributed freely under the Fair Use doctrine. Transcripts generated by Tapesearch are not guaranteed to be accurate.